Chase AIPricingFAQs
Display currency
Loading news…

Imanis Life Sciences

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Rochester, Minnesota, United States Founded 2012 1-10 employees For Profit

Imanis is a biotechnology company that specializes in oncolytic virotherapy and reporter gene imaging.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
34
Patents
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
5
Active products
11
Patents granted
1
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$332K

Company Info

Founded
2012
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
1
HQ
Rochester, Minnesota, United States
Region
Great Lakes, Midwestern US

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
0.9
Trend (90d)
0

Key People at Imanis Life Sciences

President & CEO
Co-Founder
34
professional contacts at Imanis Life Sciences
Contact execs at Imanis Life Sciences

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Imanis Life Sciences

Loading news…

FAQs about Imanis Life Sciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Imanis Life Sciences - Company Profile, Full Acquisitions List, Funding and Investments